Home
About Us
Products & Services
Market Info
Market Analysis
IPO
Corporate Actions
Other Markets
Currency
Company Information
Derivative
Mutual Fund
News
Contact Us
Open Account Online
A+
|
A
|
A-
|
Home
About Us
Products & Services
Charting
Contact Us
Profit And Loss
Market
/
Corporate Information
/
Profit And Loss
Easy Menu
Mutual Fund
Fund Profile
Daily Nav
Dividend Details
Scheme Profile
Historical NAV
MF News
MF Activities
Top 10 Holdings
New Fund Offer
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Mergers
DeMergers
Change Of Name
Split Of Face Value
Equity
Top Gainer
Top Loser
Value
Volume
52 Weeks High / Low
Advance and Decline
New High / New Low
Live Indices
Index Movers
Beta Stockwise
Only Buyers/Sellers
Bulk Deals
Block Deals
Out / Under Performers
Index Constituents
Unusual Volume
Historical Returns
Exchange Holidays
IPO
ForthComing IPO
Open IPO
Close IPO
New Listing
New Issue Monitor
Basis Of Allotment
Best Performers
Draft Prospectus
Know IPO's/FAQ's
Other Markets
ADR Price
World Indices
Skindia GDR
Derivatives
Derivatives
Futures
Options
Easy Menu
Main Menu
About Us
Products & Services
Market
Branches
Contact Us
Open Demat Account
Market
Equity
IPO
Derivatives
Corporate Actions
Mutual Funds
Other Market
Currency
News
Get Quotes
|
Company Snapshot
|
Company Background
|
Board Of Directors
|
Balance Sheet
|
Profit & Loss
|
Quarterly Results
|
Key Financial Ratios
|
Share Price
|
Deliverable Volume
|
Technical Chart
Get Quotes
Company Snapshot
Company Background
Board of Directors
Balance Sheet
Profit and Loss
Quarterly Results
Key Financial Ratios
Share Price
Deliverable Volume
Technical Chart
Change Company Name
Beta Drugs Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code
535022
NSE Symbol
BETA
P/E
86.41
ISIN Demat
INE351Y01019
Div & Yield %
0
EPS
18.58
Book Value
127.83
Market Cap (Rs Cr.)
1,620.68
Face Value
10
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
INCOME :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Sales Turnover
220.20
197.62
157.87
124.85
79.46
65.32
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
220.20
197.62
157.87
124.85
79.46
65.32
Other Income
6.19
1.73
1.04
0.86
0.61
0.42
Stock Adjustments
3.70
6.97
3.17
-0.86
1.38
-0.20
Total Income
230.09
206.32
162.08
124.85
81.45
65.54
EXPENDITURE :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Raw Materials
123.50
119.27
86.47
69.86
44.83
34.61
Power & Fuel Cost
4.22
3.83
3.06
2.28
1.84
1.46
Employee Cost
15.00
11.08
10.31
6.70
4.53
3.70
Other Manufacturing Expenses
18.02
13.61
12.51
10.04
7.65
6.64
Selling & Administrative Expenses
31.10
22.77
17.08
9.61
6.23
6.59
Miscellaneous Expenses
5.22
0.50
0.42
0.31
0.45
0.37
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
197.05
171.07
129.85
98.80
65.53
53.36
Operating Profit
33.04
35.26
32.24
26.04
15.92
12.17
Interest
4.76
1.05
0.84
0.41
0.77
0.64
Gross Profit
28.28
34.21
31.40
25.63
15.15
11.53
Depreciation
7.44
4.72
6.19
5.47
5.27
2.58
Profit Before Tax
20.84
29.49
25.21
20.16
9.88
8.95
Tax
5.70
7.47
6.68
6.15
3.30
1.72
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-0.29
0.08
-0.29
-0.24
-0.40
0.13
Reported Net Profit
15.43
21.94
18.82
14.25
6.98
7.10
Extraordinary Items
-3.32
0.00
0.00
0.00
0.00
0.00
Adjusted Net Profit
18.75
21.94
18.82
14.25
6.98
7.10
Adjustment below Net Profit
-2.42
-2.18
-0.02
-0.20
0.00
0.00
P & L Balance brought forward
82.46
62.70
43.91
29.86
22.89
15.79
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
P & L Balance carried down
95.47
82.46
62.70
43.91
29.86
22.89
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
0.00
0.00
0.00
0.00
0.00
0.00
Dividend Per Share(Rs)
0.00
0.00
0.00
0.00
0.00
0.00
Earnings Per Share-Unit Curr
15.29
22.82
19.57
14.82
7.26
7.39
Earnings Per Share(Adj)-Unit Curr
15.29
22.82
18.64
14.82
6.91
7.04
Book Value-Unit Curr
127.83
120.67
100.12
80.57
65.96
58.71
Book Value(Adj)-Unit Curr
127.83
120.67
95.35
80.57
62.82
55.92